Overview

Desloratadine 5, 10 and 20mg in Patients With Cold Urticaria

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to assess the dosis of DL which is sufficient to inhibit cold urticaria symptoms.
Phase:
Phase 4
Details
Lead Sponsor:
Marcus Maurer
Collaborator:
Johannes Gutenberg University Mainz
Treatments:
Desloratadine
Loratadine